FDA Investigator Amy M Codella

Amy M Codella has conducted inspections on 14 sites in 1 countries as of 02 Nov 2004. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
14
Last Inspection Date:
02 Nov 2004
Investigator Role:
FDA Investigation Participant
Redica ID:
100008595
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amy M Codella:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Althea A Williams, Amy L Singer, Amy M Cramer, Anita R Michael, Annemarie B Randow, Annemarie Bodnar, Barbara Jwilimczyk Macri, Byungja E Marciante, Cary Greene, Charles J Chacko, Daniel J Grabicki, Dawn L Wydner, Dhaval H Patel, Dolores Harper, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Edward O'shaughnessy, Emest F Bizjak, Eric Rothschild, Erin D Mccaffery, Fred Razzaghi, Frederick F Razzaghi, Gianine E Delade, Helen B Ricalde, Helen Verdel, James R Birkenstamm, Jason M Sluzynski, Jean M Kelahan, Jessica M Monteiro, Jill M Sooter, Jill Mielziner, Johnna L Bleem, Jose M Cayuela, Josh Renzo N Ramilo, Joy Rkozlowski Klena, K Gonzlez, Karen E D'orazio, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kelli F Regenye, Kendra L Brooks, Kerry A Kurdilla, Kinh Q Mac, Kristy A Zielny, L Zam Lam, Laishan L Lam, Larry Johnson, Laura Fontan, MS, Lawrence R Johnson, Li Li, Lisa B Hall, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Maria Estrella, Mayar M Mussa, Melissa B Libby, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Msdap Gonzlezk, Nancy L Rolli, Nicholas A Violand, Paul L Bellamy, Peter R Lenahan, Raymond L Cheung, Regina T Brown, Robert G Ruff, Rodrigo Vilchez, Russell J Glapion, Samir C Gala, Sarah Forney, Schultz, Sherri J Liu, Sinai I Davis, Stephanie T Durso, Stephen J Mottola, Stephenie M Ortiz, Suchan Kim, Susan M Halsted, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Whitney S Reynolds, William R Chang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Amy M Codella's Documents

Publish Date Document Type Title
February, 2003 EIR L'OREAL USA PRODUCTS, INC. - EIR, 2003-02-26
August, 2002 EIR Glatt Air Techniques, Inc. - EIR, 2002-08-22
August, 2002 FDA 483 Glatt Air Techniques, Inc. - Form 483, 2002-08-22
June, 2003 FDA 483 JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483, 2003-06-05
June, 2003 FDA 483 Response JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483R, 2003-07-01
July, 2003 EIR Cosette Pharmaceuticals, Inc. - EIR, 2003-07-28
November, 2002 FDA 483 NutraBio Labs, Inc. - Form 483, 2002-11-08
April, 2003 EIR Domanth Inc - EIR, 2003-04-04
February, 2003 FDA 483 Aphena Pharma Solutions - New Jersey, LLC - Form 483, 2003-02-03
February, 2003 EIR Aphena Pharma Solutions - EIR, 2003-01-30
November, 2004 EIR Ethicon, Inc. - EIR, 2004-11-23
July, 2002 EIR Princeton Medical Institute - EIR, 2002-07-09
February, 2003 FDA 483 Response Aphena Pharma Solutions - New Jersey, LLC - Form 483R, 2003-02-06
April, 2003 FDA 483 Domanth Inc - Form 483, 2003-04-04
April, 2003 EIR DSM Nutritional Products, LLC - EIR, 2003-04-02
November, 2003 EIR Medicos Labs, Inc. - EIR, 2003-11-07
May, 2003 EIR Colorcon, Inc - EIR, 2003-05-07
December, 2003 EIR ChemAid Laboratories, Inc. - EIR, 2003-12-10
February, 2003 EIR Aphena Pharma Solutions - New Jersey, LLC - EIR, 2003-02-03
June, 2003 EIR JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2003-06-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more